Effective August 2, 2022, mdxhealth has acquired the Oncotype DX GPS (Genomic Prostate Score) test from Exact Sciences. To help ensure a smooth transition for patients, continue to place orders for this test through the existing Exact Sciences portal until further notice. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the Oncotype DX GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the following press release. Questions? Email: gps@mdxhealth.com

Confidence. Delivered.

LBgard® Blood Tubes will be right back.
We are expanding the applications for use.

Sign up here to stay in touch.

Thank You

Thank you for your interest in LBgard Blood Tubes. This is an automatic response. Your message has been forwarded to the appropriate personnel.

Thank you again for contacting us.

The LBgard Team at Exact Sciences